ISEQ down as results provoke lukewarm response
The ISEQ fell 16.12 points to 6602.8 this morning.
There was a subdued reaction to Elan's third quarter results. The Ireland-headquartered US pharmaceutical company has cut losses by more than $130m (€101.8m) in 2004 over the previous year.





